Patents Assigned to Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20240100086
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: August 29, 2023
    Publication date: March 28, 2024
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240101422
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: July 25, 2023
    Publication date: March 28, 2024
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • INTRADIALYTIC USE OF SODIUM NITRITE
    Publication number: 20230256005
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Application
    Filed: January 3, 2023
    Publication date: August 17, 2023
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20230183067
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: February 13, 2023
    Publication date: June 15, 2023
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220063999
    Abstract: Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20220031735
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 3, 2022
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • INTRADIALYTIC USE OF SODIUM NITRITE
    Publication number: 20210077524
    Abstract: Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
    Type: Application
    Filed: November 23, 2020
    Publication date: March 18, 2021
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • INTRADIALYTIC USE OF SODIUM THIOSULFATE
    Publication number: 20200338120
    Abstract: Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
    Type: Application
    Filed: July 13, 2020
    Publication date: October 29, 2020
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventor: Craig Sherman
  • SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140023730
    Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
    Type: Application
    Filed: October 1, 2013
    Publication date: January 23, 2014
    Applicant: Hope Medical Enterprises, Inc. dba Hope Pharmaceuticals
    Inventors: Craig Sherman, Anthony James Lepine, Catherine Marie Smith, Kevin Robert Wirtz, Erich Schulze